Nutshell Asset Management’s Rollins ROL Stock Holding History

Nutshell Asset Management’s Portfolio ROL Stock Details ROL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5M	Buy	251,875 +214,875	+581%	+$11M	3.51%	10
2026 Q1	$1.98M	Sell	37,000 -10,000	-21%	-$595K	1.07%	24
2025 Q4	$2.82M	Buy	+47,000	New	+$2.76M	1.01%	30

Other funds holding ROL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nutshell Asset Management's ROL Position: Q2 2026 in Review

Nutshell Asset Management increased its Rollins (ROL) stake by 581% in Q2 2026, buying an estimated $11M and bringing the position to 251,875 shares worth $10.5M. The position accounts for 3.51% of the portfolio, ranked #10.

Nutshell Asset Management first reported a position in ROL in Q4 2025 and has held it in 3 quarters since. 827 funds tracked by Wall St. Rank hold ROL as of Q2 2026.

Nutshell Asset Management held 251,875 shares of Rollins worth $10.5M as of Q2 2026.
Nutshell Asset Management bought 214,875 Rollins shares in Q2 2026, an estimated $11M.
Rollins made up 3.51% of Nutshell Asset Management's portfolio in Q2 2026, its #10 holding.
Nutshell Asset Management first reported a position in Rollins in Q4 2025 and has held it in 3 quarters since.
827 funds tracked by Wall St. Rank held Rollins as of Q2 2026.

Based on Nutshell Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.